In this work, using immunofluorescence (IF) images of CD8+ T lymphocytes and cancer cells, we developed a machine-learning approach to predict the risk of relapse for patients with Triple Negative Breast Cancer (TNBC). The gene discussed is CD8A; the disease is cancer.